1. Home
  2. PBMWW vs EHI Comparison

PBMWW vs EHI Comparison

Compare PBMWW & EHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBMWW
  • EHI
  • Stock Information
  • Founded
  • PBMWW N/A
  • EHI 2003
  • Country
  • PBMWW Canada
  • EHI United States
  • Employees
  • PBMWW 10
  • EHI N/A
  • Industry
  • PBMWW
  • EHI Investment Managers
  • Sector
  • PBMWW
  • EHI Finance
  • Exchange
  • PBMWW Nasdaq
  • EHI Nasdaq
  • Market Cap
  • PBMWW N/A
  • EHI N/A
  • IPO Year
  • PBMWW N/A
  • EHI N/A
  • Fundamental
  • Price
  • PBMWW $0.01
  • EHI $6.66
  • Analyst Decision
  • PBMWW
  • EHI
  • Analyst Count
  • PBMWW 0
  • EHI 0
  • Target Price
  • PBMWW N/A
  • EHI N/A
  • AVG Volume (30 Days)
  • PBMWW N/A
  • EHI 44.5K
  • Earning Date
  • PBMWW N/A
  • EHI 01-01-0001
  • Dividend Yield
  • PBMWW N/A
  • EHI 11.54%
  • EPS Growth
  • PBMWW N/A
  • EHI N/A
  • EPS
  • PBMWW N/A
  • EHI N/A
  • Revenue
  • PBMWW N/A
  • EHI N/A
  • Revenue This Year
  • PBMWW N/A
  • EHI N/A
  • Revenue Next Year
  • PBMWW N/A
  • EHI N/A
  • P/E Ratio
  • PBMWW N/A
  • EHI N/A
  • Revenue Growth
  • PBMWW N/A
  • EHI N/A
  • 52 Week Low
  • PBMWW N/A
  • EHI $6.00
  • 52 Week High
  • PBMWW N/A
  • EHI $7.75
  • Technical
  • Relative Strength Index (RSI)
  • PBMWW N/A
  • EHI 48.37
  • Support Level
  • PBMWW N/A
  • EHI $6.67
  • Resistance Level
  • PBMWW N/A
  • EHI $6.71
  • Average True Range (ATR)
  • PBMWW 0.00
  • EHI 0.07
  • MACD
  • PBMWW 0.00
  • EHI -0.01
  • Stochastic Oscillator
  • PBMWW 0.00
  • EHI 33.33

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: